This Is America’s Favorite Credit Card
According to consumers, it does pay to Discover.
For the second year in a row, Discover has ranked the highest in customer satisfaction among credit card issuers, according to the results of a new survey by J.D. Power.
Discover received a score of 828 out of 1,000 in the survey, based on credit card terms, billing and payment, rewards, benefits and services, and problem resolution. American Express placed second with a score of 820, and Chase ranked third at 792.
Overall satisfaction with credit cards hit a record high of 790, up from 778 last year.
Related: 3 High-Tech Ideas to Fraud-Proof Our Credit Cards
Consumers were more likely to use their rewards last year, with more than half having done so in the past six months. That could be because rewards are getting better as banks get more creative with wooing and keeping customers, many of whom are still lukewarm about spending.
“When customers feel the rewards are attractive and when they redeem rewards more frequently, satisfaction improves, they spend more, and they are more likely to recommend the card to friends and family members,” Jim Miller, J.D. Power senior director of banking services, said in a statement.
Customers who redeem rewards spend an average of $1,128 per month, compared to $645 by those who don’t redeem rewards.
Even though they’re more satisfied with their credit cards, Americans are still concerned about ID theft. Less than a third of those surveyed felt their personal information was very secure, and just 16 percent thought that security had improved since last year.
Top Reads from the Fiscal Times:
- Trump: ‘I’ve Gained Such Respect for the People That Like Me’
- Why McDonald’s Could Suddenly Be Responsible for Millions of New Employees
- Americans Want Medicare to Negotiate Better Deals on Drugs
Tax Refunds Rebound
Smaller refunds in the first few weeks of the current tax season were shaping up to be a political problem for Republicans, but new data from the IRS shows that the value of refund checks has snapped back and is now running 1.3 percent higher than last year. The average refund through February 23 last year was $3,103, while the average refund through February 22 of 2019 was $3,143 – a difference of $40. The chart below from J.P. Morgan shows how refunds performed over the last 3 years.
Number of the Day: $22 Trillion
The total national debt surpassed $22 trillion on Monday. Total public debt outstanding reached $22,012,840,891,685.32, to be exact. That figure is up by more than $1.3 trillion over the past 12 months and by more than $2 trillion since President Trump took office.
Chart of the Week: The Soaring Cost of Insulin
The cost of insulin used to treat Type 1 diabetes nearly doubled between 2012 and 2016, according to an analysis released this week by the Health Care Cost Institute. Researchers found that the average point-of-sale price increased “from $7.80 a day in 2012 to $15 a day in 2016 for someone using an average amount of insulin (60 units per day).” Annual spending per person on insulin rose from $2,864 to $5,705 over the five-year period. And by 2016, insulin costs accounted for nearly a third of all heath care spending for those with Type 1 diabetes (see the chart below), which rose from $12,467 in 2012 to $18,494.
Chart of the Day: Shutdown Hits Like a Hurricane
The partial government shutdown has hit the economy like a hurricane – and not just metaphorically. Analysts at the Committee for a Responsible Federal Budget said Tuesday that the shutdown has now cost the economy about $26 billion, close to the average cost of $27 billion per hurricane calculated by the Congressional Budget Office for storms striking the U.S. between 2000 and 2015. From an economic point of view, it’s basically “a self-imposed natural disaster,” CRFB said.
Chart of the Week: Lowering Medicare Drug Prices
The U.S. could save billions of dollars a year if Medicare were empowered to negotiate drug prices directly with pharmaceutical companies, according to a paper published by JAMA Internal Medicine earlier this week. Researchers compared the prices of the top 50 oral drugs in Medicare Part D to the prices for the same drugs at the Department of Veterans Affairs, which negotiates its own prices and uses a national formulary. They found that Medicare’s total spending was much higher than it would have been with VA pricing.
In 2016, for example, Medicare Part D spent $32.5 billion on the top 50 drugs but would have spent $18 billion if VA prices were in effect – or roughly 45 percent less. And the savings would likely be larger still, Axios’s Bob Herman said, since the study did not consider high-cost injectable drugs such as insulin.
